The omega-3 industry’s buoyant waters have been disturbed by an attack on supplement labelling practices in a San Francisco court.

Chris Kilham is a perennial of the herbals industry, a man who has for more than 20 years acted as a social, anthropological and botanical conduit between indigenous cultures in places like the Peruvian Amazon and western ingredients suppliers.

Private equity firms came in droves to Expo West looking for post-recession bargains, with dietary supplements firm in their sights. A NutraIngredients-USA.com straw poll in the supplements aisles confirmed acquisition offers were as abundant as natural and organic product launches.

John Gay, the executive director and CEO of the Washington DC-based Natural Product Association (NPA), commends industry for the lobbying effort that has led to Republican Senator John McCain agreeing to alter his highly unpopular Bill.

John Gay, the executive director and CEO of the Washington DC-based Natural Product Association (NPA), commends industry for the lobbying effort that has led to Republican Senator John McCain agreeing to alter his highly unpopular Bill.

In this US regulatory round-up, New York-based food and drug attorney, Marc Ullman unpicks the reformed position of Republican Senator John McCain on the regulations governing dietary supplements.

In this US regulatory round-up, New York-based food and drug attorney, Marc Ullman unpicks the reformed position of Republican Senator John McCain on the regulations governing dietary supplements.

Kevin Pearson PhD, an assistant professor at the University of Kentucky is a long-time resveratrol researcher who is currently engaged in studying the potential of the polyphenol to benefit expectant mothers and their offspring.

Kevin Pearson PhD, an assistant professor at the University of Kentucky is a long-time resveratrol researcher who is currently engaged in studying the potential of the polyphenol to benefit expectant mothers and their offspring.

The Food and Drug Administration and the European Food Safety Authority have similar criteria in place when it comes to evaluating health claim-backing evidence – both prefer human intervention trials.